Journal of Aerosol Medicine and Pulmonary Drug Delivery

Aims & Scope

Journal of Aerosol Medicine and Pulmonary Drug Delivery is the only peer-reviewed journal delivering innovative, authoritative coverage of the health effects of inhaled aerosols and delivery of drugs through the pulmonary system.

The Journal is a forum for leading experts, addressing novel topics such as aerosolized chemotherapy, aerosolized vaccines, methods to determine toxicities, and delivery of aerosolized drugs in the intubated patient.

Journal of Aerosol Medicine and Pulmonary Drug Delivery coverage includes: Pulmonary drug delivery Airway reactivity and asthma treatment Inhalation of particles and gases in the respiratory tract Toxic effects of inhaled agents Aerosols as tools for studying basic physiologic phenomena.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.8
2024	2.00

SJR (SCImago Journal Rank)

Year	Value
2024	0.352

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	86

Journal Rank

Year	Value
2024	15088

Journal Citation Indicator

Year	Value
2024	191

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Acute Lung Injury: Epidemiology, Pathogenesis, and Treatment

  Citation: 628

  Authors: Elizabeth R., Michael A.

• The Mechanism of Breath Aerosol Formation

  Citation: 380

  Authors: Graham Richard, Lidia

• Aerosol Deposition in Health and Disease

  Citation: 356

  Authors: Chantal

• Update on Macrophage Clearance of Inhaled Micro- and Nanoparticles

  Citation: 286

  Authors: Marianne

• Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphereâ„¢ Technology

  Citation: 276

  Authors: David E., Jeffry, Silvia

• The History of Therapeutic Aerosols: A Chronological Review

  Citation: 249

  Authors: Stephen W., Charles G.

• The Particle has Landed—Characterizing the Fate of Inhaled Pharmaceuticals

  Citation: 201

  Authors: John S., Joseph D., Lee A., Jennifer, Mark, Kwang-Jin, Masahiro, Rita, Carsten

• Validation of the ‘Test of the Adherence to Inhalers’ (TAI) for Asthma and COPD Patients

  Citation: 193

  Authors: Vicente, Concepción, Carlos, Borja G., Luís Manuel, Luis Pérez, Fernando, Eduard, Rosa, Antolín

• Global Burden of Chronic Respiratory Diseases

  Citation: 188

  Authors: Giovanni, Sara, Salvatore, Sandra

• Predictors of Incorrect Inhalation Technique in Patients with Asthma or COPD: A Study Using a Validated Videotaped Scoring Method

  Citation: 168

  Authors: Geert N., Anton R.J., Henk M., Rob J.

---